文献速递性腺与生殖内分泌

抗苗勒管激素与卵巢储备:卵巢功能评估的更新

Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本综述总结血清抗苗勒管激素(AMH)作为卵巢储备标志物的近期研究进展与局限。AMH由卵巢小生长卵泡颗粒细胞产生,水平与生长卵泡数量强相关。AMH用于个体化促卵泡激素给药方案,可能预测卵巢反应不良或卵巢过度刺激综合征风险,但对持续妊娠预测价值有限;AMH缺乏国际标准且影响因素了解不足,限制检测结果比较与临床解读。

要点

  • 血清AMH水平与生长卵泡数量强相关,是首选的卵巢储备标志物。
  • AMH用于个体化FSH给药方案,可能预测卵巢反应不良或卵巢过度刺激综合征风险。
  • AMH对持续妊娠预测价值有限,且缺乏国际标准限制检测结果比较。

核心结论

  • 血清AMH仍是首选的卵巢储备标志物。
  • AMH缺乏国际标准,限制了不同AMH检测方法之间的比较。
  • 对影响血清AMH水平的内源性和外源性因素了解甚少,限制了临床环境中AMH值的正确解读。

研究设计与样本

  • 综述,通过PubMed检索近期关于血清AMH测量及其作为卵巢储备标志物应用的文献。

主要发现

  • 血清AMH水平用于评估「功能性卵巢储备」,该术语优于「卵巢储备」,因为AMH水平反映可能排卵的生长卵泡池。
  • 血清AMH水平用于个体化促卵泡激素给药方案,可能预测卵巢反应不良或卵巢过度刺激综合征的风险,但在预测持续妊娠方面价值有限。
  • 研究显示AMH随年龄下降的速率因女性而异。
  • 血清AMH测量的广泛实施导致诊断检测方法增加,包括自动化检测,但结果的直接比较仍存在问题。

局限性

  • AMH缺乏国际标准,限制了不同AMH检测方法之间的比较。
  • 对影响血清AMH水平的内源性和外源性因素了解甚少,限制了临床环境中AMH值的正确解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Anti-müllerian hormone (AMH) is produced by granulosa cells of small, growing follicles in the ovary. Serum AMH levels strongly correlate with the number of growing follicles, and therefore AMH has received increasing attention as a marker for ovarian reserve. This review summarizes recent findings and limitations in the application of serum AMH in ovarian reserve assessment. EVIDENCE ACQUISITION: A PubMed search was conducted to find recent literature on the measurements and use of serum AMH as a marker for ovarian reserve. EVIDENCE SYNTHESIS: Serum AMH levels are measured to assess the "functional ovarian reserve," a term that is preferred over "ovarian reserve," since AMH levels reflect the pool of growing follicles that potentially can ovulate. Serum AMH levels are used in individualized follicle-stimulating hormone dosing protocols and may predict the risk of poor response or ovarian hyperstimulation syndrome but has limited value in predicting ongoing pregnancy. Serum AMH levels are studied to predict natural or disease-related age of menopause. Studies show that the age-dependent decline rates of AMH vary among women. The generalized implementation of serum AMH measurement has also led to an increase in diagnostic assays, including automated assays. However, direct comparison of results remains problematic. CONCLUSION: Serum AMH remains the preferred ovarian reserve marker. However, the lack of an international standard for AMH limits comparison between AMH assays. Furthermore, little is known about endogenous and exogenous factors that influence serum AMH levels, which limits proper interpretation of AMH values in a clinical setting.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Moolhuijsen LME, Visser JA. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020. PMID: 32770239. doi:10.1210/clinem/dgaa513

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。